DE29612123U1 - Dermapermeable (skin permeable) gel (ointment) for subcutaneous lipid metabolism (subcutaneous fat burning) and treatment of cellulite - Google Patents

Dermapermeable (skin permeable) gel (ointment) for subcutaneous lipid metabolism (subcutaneous fat burning) and treatment of cellulite

Info

Publication number
DE29612123U1
DE29612123U1 DE29612123U DE29612123U DE29612123U1 DE 29612123 U1 DE29612123 U1 DE 29612123U1 DE 29612123 U DE29612123 U DE 29612123U DE 29612123 U DE29612123 U DE 29612123U DE 29612123 U1 DE29612123 U1 DE 29612123U1
Authority
DE
Germany
Prior art keywords
subcutaneous
dermapermeable
cellulite
ointment
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE29612123U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KAFL JOHANN
Original Assignee
KAFL JOHANN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KAFL JOHANN filed Critical KAFL JOHANN
Priority to DE29612123U priority Critical patent/DE29612123U1/en
Publication of DE29612123U1 publication Critical patent/DE29612123U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
DE29612123U 1996-07-11 1996-07-11 Dermapermeable (skin permeable) gel (ointment) for subcutaneous lipid metabolism (subcutaneous fat burning) and treatment of cellulite Expired - Lifetime DE29612123U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE29612123U DE29612123U1 (en) 1996-07-11 1996-07-11 Dermapermeable (skin permeable) gel (ointment) for subcutaneous lipid metabolism (subcutaneous fat burning) and treatment of cellulite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE29612123U DE29612123U1 (en) 1996-07-11 1996-07-11 Dermapermeable (skin permeable) gel (ointment) for subcutaneous lipid metabolism (subcutaneous fat burning) and treatment of cellulite

Publications (1)

Publication Number Publication Date
DE29612123U1 true DE29612123U1 (en) 1996-09-12

Family

ID=8026392

Family Applications (1)

Application Number Title Priority Date Filing Date
DE29612123U Expired - Lifetime DE29612123U1 (en) 1996-07-11 1996-07-11 Dermapermeable (skin permeable) gel (ointment) for subcutaneous lipid metabolism (subcutaneous fat burning) and treatment of cellulite

Country Status (1)

Country Link
DE (1) DE29612123U1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998052512A1 (en) 1997-05-21 1998-11-26 Dornier Medizintechnik Gmbh Use of a sound pulse source
EP0989845A1 (en) * 1997-05-05 2000-04-05 PERRICONE, Nicholas V Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
EP2182960A1 (en) * 2007-07-27 2010-05-12 Galderma Laboratories Inc. Compounds, formulations, and methods for reducing skin wrinkles, creasing and sagging

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0989845A1 (en) * 1997-05-05 2000-04-05 PERRICONE, Nicholas V Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
EP0989845A4 (en) * 1997-05-05 2004-04-07 Nicholas V Perricone Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
WO1998052512A1 (en) 1997-05-21 1998-11-26 Dornier Medizintechnik Gmbh Use of a sound pulse source
DE19721218B4 (en) * 1997-05-21 2006-12-14 Dornier Medizintechnik Gmbh Using a pulse sound source
EP2182960A1 (en) * 2007-07-27 2010-05-12 Galderma Laboratories Inc. Compounds, formulations, and methods for reducing skin wrinkles, creasing and sagging
EP2182960A4 (en) * 2007-07-27 2010-10-27 Galderma Lab Inc Compounds, formulations, and methods for reducing skin wrinkles, creasing and sagging
US8440688B2 (en) 2007-07-27 2013-05-14 Galderma Laboratories Inc. Compounds, formulations and methods for reducing skin wrinkles, creasing and sagging

Similar Documents

Publication Publication Date Title
DE69716189T2 (en) Use of melatonin derivatives for skin depigmentation and preparations containing them
ATE275383T1 (en) OXADIC ACIDS AND RELATED COMPOUNDS FOR THE TREATMENT OF SKIN DISORDERS
DE3752045T2 (en) Use of hydroxycarboxylic acids and derivatives for the manufacture of topical dermatological preparations for the treatment of wrinkles
BR9801355A (en) Emulsion oil-in-water topical cosmetic composition use of an emulsion non-therapeutic skin treatment process and process of preparing an emulsion
DE68928051T2 (en) Treatment of human collagen and use as an auto-implant
BR9700993A (en) Composition and process for topical treatment of skin discolorations found below the eyes Composition and process for topical treatment of skin fat found below the eyes
DE69728245D1 (en) System for mechanical treatment of cardiac fibrillation
ID17156A (en) ANTI-COAGULAN SUBSTANCE USE IN TREATMENT OF TROMBOSIS
ATA1095A (en) SCRAPPING DEVICE FOR SCRAPPING TREATMENT OF SKIN AND BODY PARTS
BR9600628A (en) Transparent oil-in-water emulsion topical composition use of emulsion non-therapeutic treatment of the skin and / or scalp and process of preparing an emulsion
PL333284A1 (en) Methods for medicinal treatment of skin pigmentation
BR8801105A (en) COMPOSITIONS FOR SKIN CARE AND METHOD FOR SKIN TREATMENT
DE69725843D1 (en) MEANS FOR USE IN THE PHOTOTHERAPEUTIC TREATMENT OF PROLIFERATIVE SKIN DISORDER
ATE218862T1 (en) USE OF 1-HYDROXY-2-PYRIDONES TO TREAT SKIN INFECTIONS
DE69512760D1 (en) Use of melatonin to treat patients with drug addiction
DE69841550D1 (en) TREATMENT OF FIBROMYALGIA AND RELATED DISEASES
DE69829217D1 (en) DEVICE FOR THE THERAPEUTIC TREATMENT OF BLOOD VESSELS
DE69822276D1 (en) HERBAL FORMULATION WITH THERAPEUTIC AND COSMETIC USE FOR TREATING GENERAL SKIN DISEASES
DE29612123U1 (en) Dermapermeable (skin permeable) gel (ointment) for subcutaneous lipid metabolism (subcutaneous fat burning) and treatment of cellulite
ID21874A (en) USE OF 1-HYDROXY-2-PYRIDON FOR TREATMENT OF SKIN INFECTION
DE69501991D1 (en) LINOLEOYLAMIDE CERAMIDE DERIVATIVE AND ITS USE IN COSMETIC PREPARATIONS FOR TREATING DRY SKIN
ATA901396A (en) USE OF MELATONIN FOR THE TREATMENT OF PATIENTS SUGGESTED IN DRUG ADDICTION
FR2749511B1 (en) COSMETIC METHOD OF TREATMENT AND PREVENTION OF SIGNS OF AGING SKIN
ATE238796T1 (en) NUCLEOSIDE DERIVATIVES IN COMBINATION PREPARATIONS FOR THE TREATMENT OF HSV DISEASES
NO20000376D0 (en) Transdermal therapeutic system for releasing active substance through the skin into an organism and method of application to the skin

Legal Events

Date Code Title Description
R086 Non-binding declaration of licensing interest
R207 Utility model specification

Effective date: 19961024

R156 Lapse of ip right after 3 years

Effective date: 20000503